Physician Assistant · Waterbury, CT
NPI
1255668968
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
60 Westwood Ave Ste 314
Waterbury, CT, 06708
Phone (203) 574-3007
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
464 services
Medicare patients, 2024
292
Average age 73
Drug cost, 2024
$1.8M
3,686 prescriptions
Company payments, 2025
$707
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michele C Pierce was code 99214 (office e&m - established), 354 times for 223 patients. In total Michele C Pierce billed 464 services in 8 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 354 | 223 | $78.99 | $28K |
| 99204 Office E&M - New | Office | 53 | 53 | $103.50 | $5,486 |
| 99215 Office E&M - Established | Office | 20 | 18 | $114.50 | $2,290 |
| 99213 Office E&M - Established | Office | 14 | 14 | $50.48 | $707 |
| 82274 Immunoassay | Office | 13 | 13 | $15.60 | $203 |
By year: 2022 $40K for 486 services; 2023 $41K for 492 services; 2024 $37K for 464 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82274 Immunoassay | 13 | 13 | $15.60 | $203 |
Medicare prescription drug claims, 2024
In 2024, the drug Michele C Pierce prescribed most often to Medicare patients was Famotidine, with 592 prescriptions and refills. In total Michele C Pierce wrote 3,686 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 592 | 1,336 | 154 | $10K |
| Pantoprazole Sodium Generic | 575 | 1,394 | 168 | $7,203 |
| Omeprazole Generic | 253 | 632 | 74 | $5,188 |
| Linzess Linaclotide | 219 | 433 | 68 | $241K |
| Dicyclomine Hcl Generic | 212 | 391 | 71 | $4,894 |
| Lubiprostone Generic | 201 | 345 | 45 | $31K |
| Dexlansoprazole Dr Dexlansoprazole | 171 | 325 | 34 | $45K |
| Esomeprazole Magnesium Generic | 118 | 252 | 27 | $8,864 |
| Motegrity Prucalopride Succinate | 108 | 160 | 26 | $75K |
| Creon Lipase/Protease/Amylase | 87 | 122 | 25 | $177K |
| Sucralfate Generic | 85 | 118 | 28 | $11K |
| Loperamide Loperamide Hcl | 69 | 86 | 20 | $2,263 |
| Mesalamine Generic | 58 | 145 | 19 | $48K |
| Humira(Cf) Pen Adalimumab | 49 | 49 | Under 11 | $425K |
| Lactulose Generic | 47 | 59 | 12 | $1,530 |
Brand drugs: - claims; generic drugs: 2,783 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michele C Pierce $707 ($707 in general payments such as food, travel and fees) from 12 companies. The largest payer was Madrigal Pharmaceuticals with $154.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 8 | $154 |
| Gilead Sciences, Inc. GILD | 4 | $94.63 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $86.27 |
| Abbvie Inc. ABBV | 3 | $77.43 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $54.26 |
| Ardelyx, Inc. ARDX | 2 | $53.29 |
| Janssen Biotech, Inc. JNJ | 2 | $47.19 |
| Vivus LLC | 2 | $42.91 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $38.23 |
| Novo Nordisk Inc NVO | 1 | $21.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.